Agreement for combined Anteo X product in the USA
Filed with ASX · · 4 pages · English
Earlier from AnteoTech
- Key Technical Milestone Achieved for Ultranode
- AnteoBind Order Received and Life Sciences Update
- Strategic Review Outcomes
- Appointment of Interim CEO
- Half Year Results and Operational Update Presentation
Later from AnteoTech
- $2.59 million R&D Tax Incentive received
- Queensland Government Grant Funding Update
- Appointment of MD & CEO and Annual Staff Review Process
- FY2025 Full Year Appendix 4E and Annual Report
- Full Year Results and Business Update Presentation
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech